The leading cancer center in France and Europe, 3rd in the world

Gustave Roussy ranked as the third-best cancer center in the world.

Logo classement newsweek 2027

"High Quality of Care" certification awarded by the Haute Autorité de Santé.

Label de la HAS Haute Autorité de Santé : Haute Qualité des soins. Etablissement certifié avec mention

More than 40 research teams committed to the fight against cancer

Highlights

World Pancreatic Cancer Day: Let’s Take Action!

Mobilization

To mark World Pancreatic Cancer Day, we are highlighting our research program investigating resistance to daraxonrasib, a promising new treatment, led by Dr Alice Boilève and Dr Antoine Hollebecque. The aim is to understand how tumors develop resistance to the drug and identify ways to prolong its effectiveness.

Join Gustave Roussy in taking action.

Make a Donation
Photographie : deux médecins chercheurs

I have benefited from advances in research.

The story of Emilie, 40, who was treated for cancer at Gustave Roussy 

 

My outlook on life hasn’t changed. I’m alive, and I’m living my life. I’ve benefited from advances in research.

I don’t know what the future holds, but I have hope—and that’s thanks to donations and research.

Photographie Emilie

Your donations help fund patient care and state-of-the-art equipment

Our news

18 Gustave Roussy doctors and researchers named among the world’s most influential researchers in 2026

Awards & Honours

The 2026 Highly Cited Researchers list, published by Clarivate, recognises 18 doctors and researchers affiliated with Gustave Roussy. This international recognition reflects the...

Illsutration abstraite Highly Cited Researchers

Upcoming events

Focus

Interception Program: Reinventing Cancer Prevention and Screening on a National Scale.

Personalized Prevention

The Interception Program is made possible in part by the generosity of donors

Make a donation
Myriam Touren, assistante médicale Interception

Every day, Gustave Roussy turns research into tangible therapeutic advances.
Our goal: to cure 80% of cancers by 2040 by combining scientific excellence, personalized medicine, and compassionate care.

Cancer Campus® brings together all the talent needed to drive innovation

Science in the Service of Patients
  • 100,000 m²

    facilities dedicated to innovation in oncology and healthcare

  • 21

    Startups incubated in the fields of biotechnology, AI, and nuclear medicine.